Open Access

[Corrigendum] Transcriptome sequencing of human breast cancer reveals aberrant intronic transcription in amplicons and dysregulation of alternative splicing with major therapeutic implications

  • Authors:
    • Shiva Seyed Forootan
    • Joe M. Butler
    • Derek Gardener
    • Alison E. Baird
    • Andrew Dodson
    • Alistair Darby
    • John Kenny
    • Neil Hall
    • Andrew R. Cossins
    • Christopher S. Foster
    • Christine M. Gosden
  • View Affiliations

  • Published online on: July 28, 2017     https://doi.org/10.3892/ijo.2017.4087
  • Pages: 997-997
  • Copyright: © Forootan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

SHIVA SEYED FOROOTAN, JOE M. BUTLER, DEREK GARDENER, ALISON E. BAIRD, ANDREW DODSON, ALISTAIR DARBY, JOHN KENNY, NEIL HALL, ANDREW R. COSSINS, CHRISTOPHER S. FOSTER AND CHRISTINE M. GOSDEN

Int J Oncol 48:[Related article:] 130–144, 2016

After the publication of the article, the authors retrospectively noted that the name of Dr Dawn Jones, a postdoctoral researcher in the laboratory of Professor Christine Gosden, should have been added to the authors' list, whose contribution to the study greatly augmented the exploration of all the RNA products via adoption of the RNASeq (Illumina) methodology. All the existing authors agree to the inclusion of Dr Jones as a co-author, with the exception of Derek Gardener, who has retired from the Institute and is no longer contactable by e-mail (although we are confident that he would not raise any objection).

The correct author list (and affiliations) should therefore have been published as follows:

SHIVA SEYED FOROOTAN1, JOE M. BUTLER1, DEREK GARDENER1, DAWN JONES1, ALISON E. BAIRD1, ANDREW DODSON1, ALISTAIR DARBY2, JOHN KENNY2, NEIL HALL2, ANDREW R. COSSINS2, CHRISTOPHER S. FOSTER1,3 and CHRISTINE M. GOSDEN1

1Molecular Pathology Laboratory, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Faculty of Health and Life Sciences, University of Liverpool, Royal Liverpool University Hospital, Liverpool L69 3GA; 2Center for Genomic Research, University of Liverpool, Liverpool L69 7ZB; 3HCA International, Pathology Laboratories, London WC1E 6JA, UK

We regret the oversight of having failed to include Dr Dawn Jones as an author on this paper.

Related Articles

Journal Cover

September-2017
Volume 51 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Forootan SS, Butler JM, Gardener D, Baird AE, Dodson A, Darby A, Kenny J, Hall N, Cossins AR, Foster CS, Foster CS, et al: [Corrigendum] Transcriptome sequencing of human breast cancer reveals aberrant intronic transcription in amplicons and dysregulation of alternative splicing with major therapeutic implications. Int J Oncol 51: 997-997, 2017
APA
Forootan, S.S., Butler, J.M., Gardener, D., Baird, A.E., Dodson, A., Darby, A. ... Gosden, C.M. (2017). [Corrigendum] Transcriptome sequencing of human breast cancer reveals aberrant intronic transcription in amplicons and dysregulation of alternative splicing with major therapeutic implications. International Journal of Oncology, 51, 997-997. https://doi.org/10.3892/ijo.2017.4087
MLA
Forootan, S. S., Butler, J. M., Gardener, D., Baird, A. E., Dodson, A., Darby, A., Kenny, J., Hall, N., Cossins, A. R., Foster, C. S., Gosden, C. M."[Corrigendum] Transcriptome sequencing of human breast cancer reveals aberrant intronic transcription in amplicons and dysregulation of alternative splicing with major therapeutic implications". International Journal of Oncology 51.3 (2017): 997-997.
Chicago
Forootan, S. S., Butler, J. M., Gardener, D., Baird, A. E., Dodson, A., Darby, A., Kenny, J., Hall, N., Cossins, A. R., Foster, C. S., Gosden, C. M."[Corrigendum] Transcriptome sequencing of human breast cancer reveals aberrant intronic transcription in amplicons and dysregulation of alternative splicing with major therapeutic implications". International Journal of Oncology 51, no. 3 (2017): 997-997. https://doi.org/10.3892/ijo.2017.4087